Ecdel™ 9966 elastomer meets ISO 10993 and/or USP Class VI biocompatibility requirement. This product has received a Platinum level Material Health Certificate from the Cradle to Cradle Products Innovation Institute. A Material Health Certificate is awarded to products that meet the Material Health requirements of the multi-attribute Cradle to Cradle CertifiedTM Product Standard. The Cradle to Cradle Products Innovation Institute is a nonprofit organization that administers the publicly available Cradle to Cradle CertifiedTM Product Standard, which provides designers and manufacturers with criteria and requirements for continually improving product materials and manufacturing processes. The Material Health Certificate provides manufacturers with a trusted way to communicate their efforts to identify and replace chemicals of concern in their products. For more information about Cradle to Cradle certification and to obtain printable certificates for Eastman copolyesters, visit www.c2ccertified.org. Search for Eastman Chemical Company in the Material Health Certificate Registry.
Eastman Medical Disclaimer
Ecdel elastomers are plasticizer free copolyester elastomers (COPE) that offer clarity, toughness, flexibility, and chemical resistance needed in a variety of flexible packaging including flexible medical and pharmaceutical packaging applications. Ecdel elastomers are radiation, electron beam, ethylene oxide, and autoclave sterilization stable. Ecdel 9966 may be injection molded or extruded. Ecdel elastomers may be extrusion blow molded directly into bags or extruded into film for later fabrication into bags. Ecdel 9966's medium inherent viscosity makes it a good general purpose elastomer.
It is the responsibility of the medical device manufacturer ("Manufacturer") to determine the suitability of all component parts and raw materials, including any Eastman product, used in its final product in order to ensure safety and compliance with requirements of the United States Food and Drug Administration (FDA) or other international regulatory agencies.
Eastman Chemical Company products have not been designed for nor are they promoted for end uses that would be categorized by either the United States FDA or by the International Standards Organization (ISO) as implant devices. Eastman products are not intended for use in the following applications: (1) in any bodily implant applications for greater than 30 days, based on FDA-Modified ISO-10993, Part 1 “Biological Evaluation of Medical Devices” tests (including any cosmetic, reconstructive or reproductive implant applications); (2) in any cardiac prosthetic device application, regardless of the length of time involved, including, without limitation, pacemaker leads and devices, artificial hearts, heart valves, intra-aortic balloons and control systems, and ventricular bypass assisted devices, or (3) as any critical component in any medical device that supports or sustains human life.
Eastman Chemical Company products offered for the medical market have met selected FDA-Modified ISO-10993, Part 1 “Biological Evaluation of Medical Devices” tests with human tissue contact time of 30 days or less. The tests include: cytotoxicity, sensitization, irritation or intracutaneous reactivity, systemic toxicity (acute), subchronic toxicity (sub-acute), implantation, hemocompatibility. The Manufacturer is responsible for the biological evaluation of the finished medical device.
The suitability of an Eastman Product in a given end-use environment is dependent upon various conditions including, without limitation, chemical compatibility, temperature, part design, sterilization method, residual stresses, and external loads. It is the responsibility of the Manufacturer to evaluate its final product under actual end-use requirements and to adequately advise and warn purchasers and users thereof.
Unless noted otherwise, properties reported here are typical of average lots. Eastman makes no representation that the material in any particular shipment will conform exactly to the values given.